Partnering Webinars

  1. Successful Implementation Of A Drug-Device Combination Submission 11/21/2025

    Projects including both drug and device components require strategic planning for smooth initiation. Regulatory considerations are the key to success.

  2. How Small Biotechs Can Afford An FSP Model 11/7/2025

    Lois Kelly explains how smaller biopharma companies can make an FSP model work even with limited budgets. She details how she built her own RFPs, compared boutique and large CROs, and emphasized governance, alignment, and relationships over cost alone.

  3. Why Big Pharma Is Shifting Toward FSP Solutions 11/7/2025

    Samir Shah describes how large pharmaceutical companies are moving decisively toward FSP-derived models. He explains how AI investments, cost efficiency, and improved control over operations are driving a lasting structural shift — not a short-term trend — across the industry.

  4. Embedding FSP Teams Into The Company Culture 11/7/2025

    In this segment, Lois Kelly, VP of Research and Clinical Operations at the National Down Syndrome Society, describes how shared holidays, team events, and open communication helped FSP staff feel valued.

  5. FSP Vs. FSO: It's No Longer Binary 11/7/2025

    Samir Shah, Principal at Shaw Pharma Consulting Services, outlines how today’s outsourcing exists on a continuum — where companies mix elements of both models based on their core and critical competencies rather than forcing a one-size-fits-all structure.

  6. Choosing The Right Outsourcing Model Starts With Strategy 11/7/2025

    Before picking an outsourcing model, companies must know what they’re trying to achieve. Jeremy Weitz, Director of Procurement for Global Clinical Services at Biogen, explains how aligning operating models with business strategy leads to better scalability, flexibility, and quality outcomes.

  7. 'Country in a Box' And Other Smart Outsourcing Moves 11/7/2025

    Jeremy Weitz breaks down the “country in a box” approach — a flexible FSP model that lets sponsors operate efficiently in countries where they lack a local footprint.

  8. How To Select The Right Bioanalysis CRO For Your Program 11/3/2025

    The right bioanalysis CRO accelerates progress, while the wrong one can derail outcomes. When every provider claims speed and credibility, how do you confidently choose the right partner?

  9. Biosimilar Development: Early-Stage Characterization To QC Release 10/15/2025

    SGS provides a complete range of bioanalytical solutions, including method development, validation and transfer; PK and PD Bioanalysis, ELISA and multiplex assays, bioassays, immunogenicity testing.

  10. From First-In-Human To Proof-Of-Concept — Quicker, Smarter, Streamlined 10/14/2025

    Explore examples of smarter SAD/MAD trial designs including multi-part and hybrid protocols, regulatory foresight, recruitment considerations, and operational strategies that keep programs moving.